Findings may lead to design of new drugs
Scientists at Northwestern University have acquired new insight into how a specialized sensor protein that acts as an early warning system detects dangerous amounts of the "coinage metals" - silver, gold and copper - inside cells. For the first time, researchers can explain this important mechanism at the atomic level.
The findings, published in the journal Science and recently published online by the Journal of the American Chemical Society, should improve our knowledge of diseases related to copper metabolism and influence the design of anticancer and antimicrobial drugs. The research may lead to better methods for removing toxic metals from the environment.
By studying the inorganic chemistry of the bacterium E. coli, a research team led by Thomas V. O´Halloran, professor of chemistry at Northwestern, established the molecular and structural basis for the cell´s early detection of miniscule amounts of copper. The work was done in collaboration with Alfonso Mondragon, professor of biochemistry, molecular biology and cell biology at Northwestern, and James E. Penner-Hahn, professor of chemistry at the University of Michigan.
Having determined the structures of copper-, silver- and gold-bound forms of the metalloregulatory protein CueR, the researchers were able to show the protein´s extraordinary sensitivity to copper as well as how the cell distinguishes copper from other metals, such as gold and silver.
"Metals are absolutely essential to the healthy functioning of all cells in the human body," said O´Halloran. "But metals are high-maintenance nutrients. They are finicky and can be particularly destructive if not managed by the cell in the right way. Cells must protect themselves against excess amounts."
O´Halloran likened the cell to a city in which metal ions are similar to important and reactive fuels that must be imported and then carefully delivered from one part of the city to another. Reactive metals such as copper have the potential to catalyze runaway reactions that could harm the cell, much as a series of explosions could damage critical systems in a city. Understanding how a cell properly deals with copper and other potentially toxic metals will aid biomedical researchers in understanding what happens when things go awry in cancer and neurodegenerative disorders, such as Wilson´s, Menkes and Lou Gehrig´s diseases and possibly Alzheimer´s disease.
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

VWR International, S. de R.L. de C.V. - Tultitlán, Mexico

ROBATEL S.A. - Genas, France

Garlic can fight chronic infections

Immune responses in chronic inflammatory bowel diseases - New population of immune cells that is highly abundant in Crohn’s disease patients
Hospire names Svend Andersen to lead Europe, Middle East and Africa
'Heroes of Chemistry': Developed new drugs and technology to cut heating and cooling bills
Keryx Biopharmaceuticals Announces Positive Top-Line Results from Phase 3 Study of Ferric Citrate

Asthma drug from the garden center
Treatment of the first HIV positive patient in ABIVAX’s Phase IIa clinical trial with ABX464
